{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:57:35Z","timestamp":1791187055229,"version":"4.1.0"},"reference-count":37,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The ability to modify responses to type I interferons (IFNs) could alter processes such as hematopoiesis and immunity, which involve endogenous IFNs and responses to exogenous IFNs. The data presented here support a significant role for a recently identified soluble isoform of the murine type I IFN receptor, muIfnar-2a, as an efficient regulator of IFN responses. The messenger RNA (mRNA) transcript encoding muIfnar-2a is generally more abundant than that encoding the transmembrane isoform, muIfnar-2c. Furthermore, the ratio ofmuIfnar-2a:2c transcripts varied from more than 10:1 in the liver and other organs to less than 1:1 in bone-marrow macrophages, indicating independent regulation of the 2 transcripts encoding receptor isoforms and suggesting that the soluble muIfnar-2a levels are biologically relevant in some organs. Western blot analysis showed that soluble muIfnar-2 was present at high levels in murine serum and other biologic fluids and bound type I IFN. Recombinant muIfnar-2a competitively inhibited the activity of both IFN\u03b1 and \u03b2 in reporter assays using the L929 cell line and in antiproliferative and antiviral assays using primary cells. Surprisingly, using primary thymocytes fromIfnar-2\u2212\/\u2212 mice, recombinant muIfnar-2a formed a complex with IFN \u03b1 or \u03b2 and muIfnar-1 at the cell surface and transmitted an antiproliferative signal. These data indicate potential dual actions of soluble muIfnar-2 and imply that a signal can be transduced through the Ifnar-1 chain of the receptor complex in the absence of the cytoplasmic domain of Ifnar-2. Therefore, our results suggest that soluble Ifnar-2 is an important regulator of endogenous and systemically administered type I IFN.<\/jats:p>","DOI":"10.1182\/blood.v97.2.473","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"473-482","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":96,"title":["The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties"],"prefix":"10.1182","volume":"97","author":[{"given":"Matthew P.","family":"Hardy","sequence":"first","affiliation":[{"name":"From the Center for Functional Genomics and Human Disease, Monash Institute of Reproduction and Development, Monash University, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Owczarek","sequence":"additional","affiliation":[{"name":"From the Center for Functional Genomics and Human Disease, Monash Institute of Reproduction and Development, Monash University, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Trajanovska","sequence":"additional","affiliation":[{"name":"From the Center for Functional Genomics and Human Disease, Monash Institute of Reproduction and Development, Monash University, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Center for Functional Genomics and Human Disease, Monash Institute of Reproduction and Development, Monash University, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Kola","sequence":"additional","affiliation":[{"name":"From the Center for Functional Genomics and Human Disease, Monash Institute of Reproduction and Development, Monash University, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Hertzog","sequence":"additional","affiliation":[{"name":"From the Center for Functional Genomics and Human Disease, Monash Institute of Reproduction and Development, Monash University, Clayton, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020012417543126900_B1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","article-title":"Interferons and their actions.","volume":"56","author":"Pestka","year":"1987","journal-title":"Ann Rev Biochem."},{"key":"2020012417543126900_B2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons.","volume":"67","author":"Stark","year":"1998","journal-title":"Ann Rev Biochem."},{"key":"2020012417543126900_B3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/mrd.1080390216","article-title":"Role of interferons in the regulation of cell proliferation, differentiation, and development.","volume":"39","author":"Hertzog","year":"1994","journal-title":"Mol Rep Devel."},{"key":"2020012417543126900_B4","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.4049\/jimmunol.156.7.2553","article-title":"Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha.","volume":"156","author":"Hamilton","year":"1996","journal-title":"J Immunol."},{"key":"2020012417543126900_B5","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.161.4.1947","article-title":"Type I IFNs enhance the terminal differentiation of dendritic cells.","volume":"161","author":"Luft","year":"1998","journal-title":"J Immunol."},{"key":"2020012417543126900_B6","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo.","volume":"272","author":"Tough","year":"1996","journal-title":"Science."},{"key":"2020012417543126900_B7","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1073\/pnas.91.4.1198","article-title":"Cytokine therapeutics\u2014lessons from interferon alpha.","volume":"91","author":"Gutterman","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417543126900_B8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0079-6603(08)60026-4","article-title":"The interferon genes.","volume":"33","author":"Weissmann","year":"1986","journal-title":"Prog Nucleic Acid Res Mol Biol."},{"key":"2020012417543126900_B9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jir.1995.15.3","article-title":"Alpha and beta interferons and their receptor and their friends and relations.","volume":"15","author":"Uze","year":"1995","journal-title":"J Interferon Cytokine Res."},{"key":"2020012417543126900_B10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(90)90738-Z","article-title":"Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA.","volume":"60","author":"Uze","year":"1990","journal-title":"Cell."},{"key":"2020012417543126900_B11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0092-8674(94)90154-6","article-title":"The human interferon alpha\/beta receptor: characterization and molecular cloning.","volume":"77","author":"Novick","year":"1994","journal-title":"Cell."},{"key":"2020012417543126900_B12","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1073\/pnas.89.10.4774","article-title":"Behavior of a cloned murine interferon alpha\/beta receptor expressed in homospecific or heterospecific background.","volume":"89","author":"Uze","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417543126900_B13","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1002\/j.1460-2075.1995.tb00192.x","article-title":"Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster.","volume":"14","author":"Lutfalla","year":"1995","journal-title":"EMBO J."},{"key":"2020012417543126900_B14","doi-asserted-by":"crossref","first-page":"23865","DOI":"10.1074\/jbc.272.38.23865","article-title":"Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2.","volume":"272","author":"Owczarek","year":"1997","journal-title":"J Biol Chem."},{"key":"2020012417543126900_B15","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense.","volume":"264","author":"Muller","year":"1994","journal-title":"Science."},{"key":"2020012417543126900_B16","doi-asserted-by":"crossref","first-page":"11284","DOI":"10.1073\/pnas.92.24.11284","article-title":"A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses.","volume":"92","author":"Hwang","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417543126900_B17","doi-asserted-by":"crossref","first-page":"21606","DOI":"10.1074\/jbc.270.37.21606","article-title":"Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling.","volume":"270","author":"Domanski","year":"1995","journal-title":"J Biol Chem."},{"key":"2020012417543126900_B18","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/MCB.15.8.4208","article-title":"Ligand-induced association of the type I interferon receptor components.","volume":"15","author":"Cohen","year":"1995","journal-title":"Mol Cell Biol."},{"key":"2020012417543126900_B19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MCB.2.6.617","article-title":"Transcripts from the cellular homologues of retroviral oncogenes: distribution among chicken tissues.","volume":"2","author":"Gonda","year":"1982","journal-title":"Mol Cell Biol."},{"key":"2020012417543126900_B20","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/MCB.5.12.3610","article-title":"Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.","volume":"5","author":"Evan","year":"1985","journal-title":"Mol Cell Biol."},{"key":"2020012417543126900_B21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","article-title":"Site-directed mutagenesis by overlap extension using the polymerase chain reaction.","volume":"77","author":"Ho","year":"1989","journal-title":"Gene."},{"key":"2020012417543126900_B22","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1093\/nar\/18.17.5322","article-title":"pEF-BOS, a powerful mammalian expression vector.","volume":"18","author":"Mizushima","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"2020012417543126900_B23","doi-asserted-by":"crossref","first-page":"23976","DOI":"10.1074\/jbc.272.38.23976","article-title":"The unusual species cross-reactivity of the leukemia inhibitory factor receptor alpha-chain is determined primarily by the immunoglobulin-like domain.","volume":"272","author":"Owczarek","year":"1997","journal-title":"J Biol Chem."},{"key":"2020012417543126900_B24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/elps.1150090106","article-title":"Improved silver stain procedure for fast staining in PhastSystem development unit: I, staining of sodium dodocyl sulfate gels.","volume":"9","author":"Heukeshoven","year":"1988","journal-title":"Electrophoresis."},{"key":"2020012417543126900_B25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem."},{"key":"2020012417543126900_B26","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1993.tb06023.x","article-title":"Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant.","volume":"12","author":"Owczarek","year":"1993","journal-title":"EMBO J."},{"key":"2020012417543126900_B27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08977199209011015","article-title":"Affinity conversion of receptors for colony stimulating factors: properties of solubilized receptors.","volume":"6","author":"Nicola","year":"1992","journal-title":"Growth Factors."},{"key":"2020012417543126900_B28","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1073\/pnas.89.18.8616","article-title":"A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor.","volume":"89","author":"Layton","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417543126900_B29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1073\/pnas.75.1.248","article-title":"In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase.","volume":"75","author":"Maller","year":"1978","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020012417543126900_B30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0090-1229(91)90145-Z","article-title":"Intermittent interferonemia and interferon responses in multiple sclerosis.","volume":"58","author":"Hertzog","year":"1991","journal-title":"Clin Immunol Immunopathol."},{"key":"2020012417543126900_B31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0378-1119(97)00240-0","article-title":"Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2.","volume":"196","author":"Kim","year":"1997","journal-title":"Gene."},{"key":"2020012417543126900_B32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0092-8674(90)90163-9","article-title":"Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated.","volume":"63","author":"Harada","year":"1990","journal-title":"Cell."},{"key":"2020012417543126900_B33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3000281","article-title":"Soluble receptors for cytokines and growth factors-generation and biological function.","volume":"300","author":"Rosejohn","year":"1994","journal-title":"Biochem J."},{"key":"2020012417543126900_B34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0161-5890(92)90027-U","article-title":"Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a\u2014subtype reactivity, neutralisation of biological activities and epitope analysis.","volume":"29","author":"Overall","year":"1992","journal-title":"Mol Immunol."},{"key":"2020012417543126900_B35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/eji.1830230515","article-title":"Serum soluble interleukin-6 receptor in MRL\/lpr mice is elevated with age and mediates the interleukin-6 signal.","volume":"23","author":"Suzuki","year":"1993","journal-title":"Eur J Immunol."},{"key":"2020012417543126900_B36","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1074\/jbc.272.17.11002","article-title":"The short form of the interferon alpha\/beta receptor chain 2 acts as a dominant negative for type I interferon action.","volume":"272","author":"Pfeffer","year":"1997","journal-title":"J Biol Chem."},{"key":"2020012417543126900_B37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/37648","article-title":"Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling.","volume":"390","author":"Petricoin","year":"1997","journal-title":"Nature."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/2\/473\/1590474\/473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/97\/2\/473\/1590474\/473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T06:41:42Z","timestamp":1704523302000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/97\/2\/473\/52842\/The-soluble-murine-type-I-interferon-receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,15]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v97.2.473","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1,15]]}}}